OS Therapies Inc. - OSTX Future Profit

OSTX (OS Therapies Inc.) - company brandmark

OS Therapies Incorporated (OSTX) is developing a portfolio of drugs against pediatric solid tumors, seeking partnerships with biotech giants. The specifics of osteosarcoma treatment render the business insensitive to macroeconomics and inflation. The expected net profit of the business is supported by this chart from GURU.Markets, which confirms a trend where the 0.00 parameter determines the metric's value. Management is focused on creating innovative immunotherapy for rare types of cancer.

OSTX: ostherapies.com Future Profit 09/08/2024 - 04/03/2025

OS Therapies Inc - analytical breakdowns and key metrics (OSTX)

- price and consensus price forecast:
Fundamental company analysis:OSTX, OS Therapies, Inc.
Core merchandise of OS Therapies Inc.

This metric determines the issuer's potential net income based on the balance of market supply and demand. The calculation is based on the extrapolation of current cash flows and is sensitive to any changes in financial reporting. By analyzing the expected net profit metric, an investor can filter out unfounded management optimism. For OS Therapies Incorporated (OSTX), this metric reflects the commercial viability of therapies for rare pediatric oncological diseases. Success in preserving patients' limbs converts directly into future capitalization.

Competitors of OS Therapies Incorporated

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit